On March 1, 2019, Shanghai Luoqi Bio-pharmaceutical Technology Co., Ltd. and Zhejiang Terex Pharmaceutical Co., Ltd. signed a global strategic cooperation agreement, announcing that the two sides will carry out cooperation in various aspects in the field of tumor immunotherapy and nano-antibody drugs, with strong cooperation, complementary advantages and win-win cooperation. Dr. Wan Yakun, chairman of Rocky Biology, and Dr. Wu Youling, chief executive officer and chairman of Trisys Pharmaceutical attended the ceremony and signed. Xiong Quanlong, deputy director of the Standing Committee of Huzhou Municipal People's Congress and secretary of the Party Committee of the Development Zone, attended the ceremony and delivered an important speech.

On October 30, Luoqi Biology was invited to participate in the "Opening Ceremony of the 8th China Innovation and Entrepreneurship Competition (Shanghai) and 2019 Entrepreneurship in Shanghai International Innovation and Entrepreneurship Competition". At the ceremony, relevant leaders presented awards to the winners of the 2018 "Entrepreneurship in Shanghai" International Innovation and Entrepreneurship Competition.

From October 16, 2017 to October 16, 2018, the first anniversary of the founding of Rocky Biology! We are a group of young partners who are deeply engaged in the field of antibody drugs. This year, we have been moving forward, and this year, we have gained a lot!